PMV Pharmaceuticals Inc expected to post a loss of 41  cents a share - Earnings Preview

Pmv Pharmaceuticals

09/08/2022 13:12

* PMV Pharmaceuticals Inc  PMVP.OQ   PMVP.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 11 (estimated). 
    * ​Refinitiv's mean analyst estimate for PMV Pharmaceuticals
Inc
is for a loss of 41 cents per share. For the same quarter last
year, the company reported a loss of 29 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $41.5​, above​ its last closing price
of $17.12. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.43       -0.40      -0.41     Missed  -1.7
 Dec. 31 2022  -0.35       -0.35      -0.40     Missed  -15.4
 Sep. 30 2021  -0.30       -0.30      -0.33     Missed  -9.4​
 Jun. 30 2021  -0.30       -0.28      -0.29     Missed  -2.8
 ​​Mar.        -0.24       -0.24      -0.26     Missed  -8.3
 31 2021                                                
 Dec. 31 2020              -0.57                        ​
 Sep. 30 2020  -0.34       -0.34      -1.46     Missed  -323.2
 This summary was machine generated August 9 at 12:12 GMT.  All
figures in US dollars  unless otherwise stated